Chinese General Practice ›› 2024, Vol. 27 ›› Issue (06): 637-642.DOI: 10.12114/j.issn.1007-9572.2023.0479
• Review & Perspectives • Previous Articles Next Articles
Received:
2023-07-21
Revised:
2023-08-27
Published:
2024-02-20
Online:
2023-11-21
Contact:
LI Jie
通讯作者:
李婕
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0479
区域 | 发病率 | 死亡率 | ||
---|---|---|---|---|
例数 | ASIR(1/10万) | 例数 | ASMR(1/10万) | |
所有区域 | 364 800 | 17.81 | 318 800 | 15.29 |
城市 | 192 200 | 16.13 | 166 100 | 13.64 |
农村 | 172 600 | 20.07 | 152 700 | 17.52 |
东部地区 | 122 900 | 15.31 | 152 700 | 13.52 |
中部地区 | 122 900 | 18.23 | 152 700 | 15.97 |
西部地区 | 116 100 | 20.85 | 96 200 | 16.98 |
Table 1 Incidence and mortality of primary liver cancer in China
区域 | 发病率 | 死亡率 | ||
---|---|---|---|---|
例数 | ASIR(1/10万) | 例数 | ASMR(1/10万) | |
所有区域 | 364 800 | 17.81 | 318 800 | 15.29 |
城市 | 192 200 | 16.13 | 166 100 | 13.64 |
农村 | 172 600 | 20.07 | 152 700 | 17.52 |
东部地区 | 122 900 | 15.31 | 152 700 | 13.52 |
中部地区 | 122 900 | 18.23 | 152 700 | 15.97 |
西部地区 | 116 100 | 20.85 | 96 200 | 16.98 |
危险因素 | 总人群 | 男性 | 女性 |
---|---|---|---|
HBV感染 | 53.2 | 55.6 | 46.5 |
HCV感染 | 17.0 | 17.4 | 15.9 |
吸烟 | 12.8 | 15.7 | 4.8 |
饮酒 | 7.9 | 10.3 | 1.6 |
DM | 10.4 | 10.9 | 8.8 |
肥胖 | 11.0 | 10.3 | 13.0 |
Table 2 Population attributable fractions of risk factors for primary liver cancer in China
危险因素 | 总人群 | 男性 | 女性 |
---|---|---|---|
HBV感染 | 53.2 | 55.6 | 46.5 |
HCV感染 | 17.0 | 17.4 | 15.9 |
吸烟 | 12.8 | 15.7 | 4.8 |
饮酒 | 7.9 | 10.3 | 1.6 |
DM | 10.4 | 10.9 | 8.8 |
肥胖 | 11.0 | 10.3 | 13.0 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
安澜,曾红梅,郑荣寿,等. 2015年中国肝癌流行情况分析[J]. 中华肿瘤杂志,2019,41(10):721-727. DOI:10.3760/cma.j.issn.0253?3766.2019.10.001.
|
[9] |
曾红梅,曹毛毛,郑荣寿,等. 2000—2014年中国肿瘤登记地区肝癌发病年龄变化趋势分析[J]. 中华预防医学杂志,2018,52(6):573-578. DOI:10.3760/cma.j.issn.0253-9624.2018.06.004.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
陈万青,崔富强,樊春笋,等. 中国肝癌一级预防专家共识(2018)[J]. 临床肝胆病杂志,2018,34(10):2090-2097.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
陈曦阳光,吴君. 乙型肝炎肝硬化并发原发性肝癌相关危险因素Meta分析[J]. 肝脏,2019,24(4):398-404. DOI:10.14000/j.cnki.issn.1008-1704.2019.04.019.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
丁惠国,屠红,曲春枫,等. 原发性肝癌的分层筛查与监测指南(2020版)[J]. 临床肝胆病杂志,2021,37(2):286-295.
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
|
[1] | WANG Qingyu, LIN Zheng, LEI Yang, SUN Caiyun, WANG Mi, GU Junyi, ZHU Zhanhui, TANG Lichen. Assessment and Treatment of Avoidant/Restrictive Food Intake Disorder in Children and Adolescents [J]. Chinese General Practice, 2024, 27(09): 1028-1033. |
[2] | WANG Xueting, JIANG Yi. Disease Burden of Chronic Obstructive Pulmonary Disease in the BRICS Countries from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(09): 1118-1125. |
[3] | HAN Junjie, WU Di, CHEN Zhisheng, XIAO Yang, SEN Gan. A Nomogram Prediction Model and Validation Study on the Risk of Complicated Diabetic Nephropathy in Type 2 Diabetes Patients [J]. Chinese General Practice, 2024, 27(09): 1054-1061. |
[4] | WANG Kai, XU Baichao, WANG Zhaoxin, SU Jianjiao. Effects of Combined Motion Intervention on Body Composition, Cardiovascular Risk Factors and Cardiopulmonary Fitness of Obese Female Adolescents [J]. Chinese General Practice, 2024, 27(09): 1109-1117. |
[5] | CHEN Wenjin, CHEN Piaoying, YANG Xiaohua, CHEN Yifan, CAI Yefeng, NI Xiaojia. Advance in Epidemiologic Studies of Dietary Patterns Associated with Cerebrovascular Diseases [J]. Chinese General Practice, 2024, 27(08): 900-907. |
[6] | YUAN Yuan, ZHANG Yarong, LI Zhengang, ZHANG Li. Risk Factors of Prone Position Ventilation-related Facial Pressure Injuries and the Selection of Best Modeling Method [J]. Chinese General Practice, 2024, 27(08): 948-954. |
[7] | Quality Assessment Group for Quantitative Research,Systematic Review and Guidelines/Consensus of Chinese General Practice. Report on Methodological Quality Assessment of Primary Care and General Practice Research in China in 2021: Quantitative Research, Systematic Review and Guidelines/Consensus Section [J]. Chinese General Practice, 2024, 27(07): 773-783. |
[8] | ZHANG Jinxin, YAO Nengliang, SUN Xiaojie. Qualitative Studies on Care and Support Needs in Elderly People with Physical Disability: a Systematic Review [J]. Chinese General Practice, 2024, 27(07): 867-876. |
[9] | PENG Lei, ZHU Kexiang. Research Progress of Sarcopenic Obesity in Cancer [J]. Chinese General Practice, 2024, 27(06): 643-649. |
[10] | DONG Wendi, YANG Jiani, ZHU Jie, QUAN Yujie, ZHANG Jinjing, LIU Yan, ZHANG Hairong. Study of Factors Associated with Concomitant Gastrointestinal Bleeding in Patients with Portal Vein Thrombosis in Liver Cirrhosis [J]. Chinese General Practice, 2024, 27(05): 552-556. |
[11] | NIU Luyao, YING Xinyu, ZHANG Shuqin, AN Zhixin, JI Jingya, LIU Yuehua, GAO Yuexia. Practice and Reflection on Diabetes Community Management Model from the Perspective of Value Co-creation [J]. Chinese General Practice, 2024, 27(05): 563-569. |
[12] | ZHANG Xiaoyi, XU Zhihan, YUAN Beibei, WANG Sheng, LIU Xiao, ZHOU Huilan, LI Zhansheng. Patterns and Effects of Collaboration between Primary Care Providers and Medical Specialists in the Delivery of Integrated Health Care Services: a Scoping Review [J]. Chinese General Practice, 2024, 27(04): 400-407. |
[13] | ZHANG Zhengyan, WANG Zhenzhong, ZHANG Ji, GONG Enying, SHAO Ruitai. Current Status and Implications of Ecology of Medical Care Model in Health Services Research: a Scoping Review [J]. Chinese General Practice, 2024, 27(04): 391-399. |
[14] | DENG Yuxuan, HUANG Xuejun, JIANG Yanxia. Recent Advances of Metformin in Treatment of Diabetic Nephropathy [J]. Chinese General Practice, 2024, 27(03): 262-267. |
[15] | FAN Caixia, LI Jiao, WEI Yanjin, GUO Dequn, LIU Cunfei, LI Zhengrong, QIU Shi. Influencing Factors of Overanticoagulation at Initial Stage of Warfarin Anticoagulation Therapy in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2024, 27(03): 308-314. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||